Human Fc IgA anti-RBD

0 (0 Reviews)
Our human chimeric IgA anti-RDB antibody is known to be the best alternative to characterized disease state plasma. They are used as positive controls and calibrators for IVD kits, which are critical components in assay development.
Specification

After immunization with SARS-CoV-2 RBD antigen of Hamiga® mouse, a transgenic mouse whose sequence for the Ig heavy chain constant region is replaced by a human IgA sequence, a hybridoma cell line has been established.

  • High affinity
  • High reactivity: sensitivity, specificity, selectivity, stability
  • Industrial batch-to-batch reproducibility
  • Constant availability
  • Constant quality and performance
Certificates of Analysis (COA)
Product Information
Product Code
BCD-94-SRB-A-C1
Clone
IB3C4
Host
Hamiga® mouse
Isotype
IgA with human Fc
Specificity
SARS-CoV-2 Receptor Binding Domain (RBD)
Applications
Control, Immunoassay (Elisa, CLIA, LFIA, WB, dots etc.)
Disease area
Infectious diseases
Purified by
Affinity chromatography
Concentration
Please see batch COA
Storage condition
Between + 2°C and + 8°C or aliquot and store frozen. Avoid repeated freeze/thaw cycles.
Shipped in
Wet ice
Shelf life
2 years from manufacturing day
Disclaimer
For in vitro research and manufacturing use only

Charts and data

IgA anti-RBD clone IB3C4 Batch PU2101018
Michel Cogné
Scientific Advisor
Bcell Design's unique, patented technology enables us to design and produce highly specific monoclonal antibodies, improving the accuracy and reliability of in-vitro diagnostics assays.

How can we help?

General enquiry
Request a free sample
Custom development services
Technical support